ELF3 and cancer: As ELF3 was expressed in prostate basal epithelial cells, BPH‐1 and PC3 cells were considered appropriate representative cell lines to initially characterise the effects of ELF3 knockdown in prostate benign and cancer cells, as they both express significant levels of ELF3 and do not have the characteristics of a luminal cell phenotype.